chr3-38726877-G-A

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_006514.4(SCN10A):​c.2816C>T​(p.Pro939Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000182 in 1,614,096 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00014 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00019 ( 1 hom. )

Consequence

SCN10A
NM_006514.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.464
Variant links:
Genes affected
SCN10A (HGNC:10582): (sodium voltage-gated channel alpha subunit 10) The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.026501745).
BP6
Variant 3-38726877-G-A is Benign according to our data. Variant chr3-38726877-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 407747.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=2}.
BS2
High AC in GnomAd4 at 21 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SCN10ANM_006514.4 linkc.2816C>T p.Pro939Leu missense_variant 17/28 ENST00000449082.3 NP_006505.4 Q9Y5Y9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SCN10AENST00000449082.3 linkc.2816C>T p.Pro939Leu missense_variant 17/281 NM_006514.4 ENSP00000390600.2 Q9Y5Y9
SCN10AENST00000643924.1 linkc.2816C>T p.Pro939Leu missense_variant 16/27 ENSP00000495595.1 A0A2R8Y6J6
SCN10AENST00000655275.1 linkc.2843C>T p.Pro948Leu missense_variant 17/28 ENSP00000499510.1 A0A590UJM0

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
152206
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000384
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.000480
GnomAD3 exomes
AF:
0.000267
AC:
67
AN:
251328
Hom.:
0
AF XY:
0.000287
AC XY:
39
AN XY:
135834
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.000598
Gnomad SAS exome
AF:
0.000261
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000220
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000186
AC:
272
AN:
1461890
Hom.:
1
Cov.:
33
AF XY:
0.000227
AC XY:
165
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00157
Gnomad4 EAS exome
AF:
0.000277
Gnomad4 SAS exome
AF:
0.000591
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000116
Gnomad4 OTH exome
AF:
0.000497
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
152206
Hom.:
1
Cov.:
33
AF XY:
0.000121
AC XY:
9
AN XY:
74364
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.000384
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000147
Gnomad4 OTH
AF:
0.000480
Alfa
AF:
0.0000956
Hom.:
0
Bravo
AF:
0.000128
ExAC
AF:
0.000222
AC:
27
EpiCase
AF:
0.000382
EpiControl
AF:
0.000415

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, no assertion criteria providedprovider interpretationStanford Center for Inherited Cardiovascular Disease, Stanford UniversityMar 09, 2017p.Pro939Leu (P939L; c.2816C>T) in exon 16 of the SCN10A gene (NM_006514.3) Chromosome position 3:38768368 G / A We classify this as a variant of uncertain significance (VUS), concluding that there is not sufficient evidence for its pathogenicity to warrant using it for diagnosis or predictive genetic testing. It has not been reported in another person with our patient’s phenotype as of 4/12/2017, it is in a gene of uncertain significance, and it is found in the general population at an appreciable frequency. This variant has been reported in one individual affected with painful peripheral neuropathy (Faber et al. 2012, PMID: 23115331). However, it did not meet the authors’ criteria to move on to functional in vitro studies (criteria: <1% allelic frequency in public databases, segregation in affected individuals when available to test, alteration of a conserved residue in a transmembrane segment or a previously identified functional motif that regulates channel current). This is a conservative amino acid change, resulting in the replacement of a nonpolar Proline with a nonpolar Leucine. Proline at this location is poorly conserved across vertebrate species, and is frequently replaced by Alanine, Serine, or Arginine. Leucine is the default amino acid in at least one mammalian species. There are no Likely Pathogenic or Pathogenic missense variants listed in ClinVar within 10 amino acids to either side as of 4/11/2017. According to the Invitae report, algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. In total the variant has been seen in at least 69 out of >140,000 individuals from publicly available population datasets. Specifically, it was reported in 16/5,069 Ashkenazi Jewish, 12/9,434 East Asian, 8/15,391 South Asian, 27/63,271 non-Finnish European, 4/17,209 Latino, and 2/3,232 “Other” ancestry individuals in the gnomAD database, which includes variant calls on ~140,000 individuals of European, African, Latino, South Asian, Ashkenazi, and East Asian descent. Out patient’s ancestry is Latino. The overall allele frequency in gnomAD is 0.02%, and the highest allele frequency is 0.16% in Ashkenazi Jews. This would translate into 1 in 317 people with Ashkenazi Jewish ancestry having the variant (which is likely too common to be a cause of Brugada syndrome). The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. The curators made an effort to exclude individuals with severe pediatric diseases. -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJan 03, 2019The P939L variant in the SCN10A gene has been reported previously as heterozygous in an individual with painful neuropathy, however it is unclear if this patient was compound heterozygous for another variant (Faber et al., 2012). The P939L variant is observed in 69/277034 (0.025%) alleles in large population cohorts (Lek et al., 2016). The P939L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. We interpret P939L as a variant of uncertain significance. -
Brugada syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 08, 2023- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 02, 2020This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
10
DANN
Benign
0.65
DEOGEN2
Benign
0.062
T;.;T;.
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.40
.;T;T;T
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.027
T;T;T;T
MetaSVM
Benign
-0.74
T
MutationAssessor
Benign
-0.035
N;.;N;.
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.83
N;.;.;.
REVEL
Benign
0.26
Sift
Benign
0.043
D;.;.;.
Sift4G
Benign
0.24
T;.;.;.
Polyphen
0.24
B;.;B;.
Vest4
0.12
MVP
0.65
MPC
0.062
ClinPred
0.013
T
GERP RS
3.4
Varity_R
0.032
gMVP
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs202174472; hg19: chr3-38768368; COSMIC: COSV104716768; API